Socio-demographic factors, health risks and harms associated with early initiation of injection among people who inject drugs in Tallinn, Estonia: Evidence from cross-sectional surveys

International Journal of Drug Policy

Volumn 24, Issue 2, 2013, Pages 150-155

  Vorobjov, Sigrid ^a   Des Jarlais, Don C ^b   Abel Ollo, Katri ^a   Talu, Ave ^a   Rüütel, Kristi ^c   Uusküla, Anneli ^a  

^a NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c UNIVERSITY OF TARTU   (Estonia)

Author keywords

Adolescents; Eastern Europe; HIV; Injecting drug use; Respondent driven sampling; Risk behaviour

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DRUG ABUSE; EDUCATIONAL STATUS; ESTONIA; FEMALE; HEALTH HAZARD; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTERVIEW; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; SEXUAL BEHAVIOR; SOCIAL ASPECT; UNEMPLOYMENT;

ADOLESCENT; ADOLESCENT BEHAVIOR; ADULT; AGE FACTORS; CHILD; CROSS-SECTIONAL STUDIES; DEMOGRAPHY; ESTONIA; FEMALE; HIV SEROPREVALENCE; HUMANS; MALE; RISK FACTORS; RISK REDUCTION BEHAVIOR; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84875378467     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2012.08.003     Document Type: Article

References (35)

1. Anthony J.C., Petronis K.R. Early onset drug use and risk of later drug problems. Drug and Alcohol Dependence 1995, 40:9-15.
2. Babor T.F., Caulkins J., Edwards G., Fischer B., Foxcroft D., Humphreys K., et al. Drug policy and the public good 2010, Oxford UP, Oxford.
3. Becker Buxton M., Vlahov D., Strathdee S.A., Des Jarlais D.C., Morse E.V., Ouellet L., et al. Association between injection practices and duration of injection among recently initiated injection drug users. Drug and Alcohol Dependence 2004, 75:177-183.
4. Cheng Y., Sherman S.G., Srirat N., Vongchak T., Kawichai S., Jittiwutikarn J., et al. Risk factors associated with injection initiation among drug users in Northern Thailand. Harm Reduction Journal 2006, 3:10.
5. Des Jarlais D.C., Friedman S.R., Perlis T., Chapman T.F., Sotheran J.L., Paone D., et al. Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 1999, 20:67-72.
6. Des Jarlais D.C., Perlis T.E., Stimson G.V., Poznyak V. Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: Case study from the WHO Drug Injection Study Phase II. BMC Public Health 2006, 6:54. WHO Phase II Drug Injection Collaborative Study Group.
7. DuRant R.H., Smith J.A., Kreiter S.R., Krowchuk D.P. The relationship between early age of onset of initial substance use and engaging in multiple health risk behaviors among young adolescents. Archives of Pediatrics & Adolescent Medicine 1999, 153:286-291.
8. Eurasian Harm Reduction Network (EHRN) Young people and injecting drug use in selected countries of Central and Eastern Europe 2009, EHRN, Vilnius.
9. Frajzyngier V., Neaigus A., Gyarmathy V.A., Miller M., Friedman S.R. Gender differences in injection risk behaviors at the first injection episode. Drug and Alcohol Dependence 2007, 89:145-152.
10. Friedman S.R., Des Jarlais D.C., Neaigus A., Abdul-Quader A., Sotheran J.L., Sufian M., et al. AIDS and the new drug injector. Nature 1989, 339:333-334.
11. Fuller C.M., Vlahov D., Arria A.M., Ompad D.C., Garfein R., Strathdee S.A. Factors associated with adolescent initiation of injection drug use. Public Health Reports 2001, 116(Suppl. 1):136-145.
12. Fuller C.M., Vlahov D., Latkin C.A., Ompad D.C., Celentano D.D., Strathdee S.A. Social circumstances of initiation of injection drug use and early shooting gallery attendance: Implications for HIV intervention among adolescent and young adult injection drug users. Journal of Acquired Immune Deficiency Syndrome 2003, 32:86-93.
13. Fuller C.M., Vlahov D., Ompad D.C., Shah N., Arria A., Strathdee S.A. High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: A case-control study. Drug and Alcohol Dependence 2002, 66:189-198.
14. Heckathorn D.D. Respondent-driven sampling II: Deriving valid population estimates from chain-referral samples of hidden populations. Social Problems 2002, 49:11-34.
15. Joint United Nations Programme on HIV/AIDS (UNAIDS). (2010). Fact sheet 2010. Retrieved from . http://www.unaids.org/documents/20101123_FS_eeca_em_en.pdf.
16. Kokkevi A., Nic Gabhainn S., Spyropoulou M. Early initiation of cannabis use: A cross-national European perspective. Journal of Adolescence Health 2006, 39:712-719. Risk Behaviour Focus Group of the HBSC.
17. Kral A.H., Lorvick J., Edlin B.R. Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighbourhoods in San Francisco. Journal of Acquired Immune Deficiency Syndrome 2000, 24:162-167.
18. Malekinejad M., Johnston L.G., Kendall C., Kerr L.R., Rifkin M.R., Rutherford G.W. Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: A systematic review. AIDS and Behavior 2008, 12(4 Suppl):S105-S130.
19. Mathers B.M., Degenhardt L., Ali H., Wiessing L., Hickman M., Mattick R.P., et al. HIV prevention, treatment, and care services for people who inject drugs: A systematic review of global, regional, and national coverage. Lancet 2010, 375:1014-1028.
20. McLellan A.T., Meyers K. Contemporary addiction treatment: A review of systems problems for adults and adolescents. Biological Psychiatry 2004, 56:764-770.
21. Merkinaite S., Grund J.P., Frimpong A. Young people and drugs: Next generation of harm reduction. International Journal of Drug Policy 2010, 21:112-114.
22. Miller C.L., Kerr T., Strathdee S.A., Li K., Wood E. Factors associated with premature mortality among young injection drug users in Vancouver. Harm Reduction Journal 2007, 4:1.
23. Miller C.L., Strathdee S.A., Kerr T., Li K., Wood E. Factors associated with early adolescent initiation into injection drug use: Implications for intervention programs. Journal of Adolescent Health 2006, 38:462-464.
24. Miller C.L., Strathdee S.A., Li K., Kerr T., Wood E. A longitudinal investigation into excess risk for blood-borne infection among young injection drug users (IDUs). American Journal of Drug and Alcohol Abuse 2007, 33:527-536.
25. Neaigus A., Friedman S.R., Jose B., Goldstein M.F., Curtis R., Ildefonso G., et al. High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 1996, 11:499-509.
26. Rhodes T., Ball A., Stimson G.V., Kobyshcha Y., Fitch C., Pokrovsky V., et al. HIV infection associated with drug injecting in the newly independent states, eastern Europe: The social and economic context of epidemics. Addiction 1999, 94:1323-1336.
27. Salganik M.J., Heckathorn D.D. Sampling and estimation in hidden populations using respondent-driven sampling. Sociological Methodology 2004, 34:193-239.
28. Sherman S.G., Fuller C.M., Shah N., Ompad D.V., Vlahov D., Strathdee S.A. Correlates of initiation of injection drug use among young drug users in Baltimore, Maryland: The need for early intervention. Journal of Psychoactive Drugs 2005, 37:437-443.
29. Sung M., Erkanli A., Angold A., Costello E.J. Effects of age at first substance use and psychiatric comorbidity on the development of substance use disorders. Drug and Alcohol Dependence 2004, 75:287-299.
30. Thorstensson R., Andersson S., Lindbäck S., Dias F., Mhalu F., Gaines H., et al. Evaluation of 14 commercial HIV-1/HIV-2 antibody assays using serum panels of different geographical origin and clinical stage including a unique seroconversion panel. Journal of Virological Methods 1998, 70:139-151.
31. Uusküla A., Des Jarlais D.C., Kals M., Rüütel K., Abel-Ollo K., Talu A., et al. Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia. BMC Public Health 2011, 11:517.
32. Uusküla A., Kalikova A., Zilmer K., Tammai L., DeHovitz J. The role of injection drug use in the emergence of Human Immunodeficiency Virus infection in Estonia. International Journal of Infectious Diseases 2002, 6:23-27.
33. Uusküla A., Rajaleid K., Talu A., Abel K., Rüütel K., Hay G. Estimating injection drug use prevalence using state wide administrative data sources: Estonia, 2004. Addiction Research & Theory 2007, 15:411-424.
34. Weber B. Multicenter evaluation of the new automated Enzymun-Test Anti-HIV 1+2+subtyp O. Journal of Clinical Microbiology 1998, 36:580-584.
35. Winters K.C. Treating adolescents with substance use disorders: An overview of practice issues and treatment outcome. Substance Abuse 1999, 20:203-225.